TY - JOUR
T1 - Enzyme immunoassays for measuring complement-dependent prevention of immune precipitation (PIP) and solubilization of preformed antigen-antibody complexes (SOL).
AU - Arason, G J
AU - D'Ambrogio, M S
AU - Vikingsdottir, T
AU - Sigfusson, A
AU - Valdimarsson, H
PY - 1999/2/1
Y1 - 1999/2/1
N2 - We have developed simple and sensitive enzyme-based methods for evaluating the ability of serum complement to prevent immune complex precipitation (PIP) or to solubilize preformed immune complexes (SOL). Alkaline phosphatase, serving both as antigen and label, is added to goat IgG anti-alkaline phosphatase antibodies, with serum present throughout the assay (PIP), or added after immune complex formation (SOL). After incubation at 37 degrees C for 1 h followed by centrifugation, the enzyme activity of the supernatant, reflecting the amount of immune complexes in solution, is measured by colorimetry. Results are expressed with reference to a standard serum pool assigned 100 arbitrary units (AU). Intra- and inter-assay variabilities are within 10%. The normal ranges were 67-133 AU for PIP and 72-129 AU for SOL. These methods have been standardized for clinical use in relation to impaired complement function and immune complex disease, and adapted for measuring complement mediated binding of immune complexes to erythrocytes. They are sensitive, easy to perform and do not require expensive facilities. By measuring the interaction of complement with immune complexes, these methods may highlight aspects of the classical and the alternative pathway that are different from those detected using haemolysis as an endpoint.
AB - We have developed simple and sensitive enzyme-based methods for evaluating the ability of serum complement to prevent immune complex precipitation (PIP) or to solubilize preformed immune complexes (SOL). Alkaline phosphatase, serving both as antigen and label, is added to goat IgG anti-alkaline phosphatase antibodies, with serum present throughout the assay (PIP), or added after immune complex formation (SOL). After incubation at 37 degrees C for 1 h followed by centrifugation, the enzyme activity of the supernatant, reflecting the amount of immune complexes in solution, is measured by colorimetry. Results are expressed with reference to a standard serum pool assigned 100 arbitrary units (AU). Intra- and inter-assay variabilities are within 10%. The normal ranges were 67-133 AU for PIP and 72-129 AU for SOL. These methods have been standardized for clinical use in relation to impaired complement function and immune complex disease, and adapted for measuring complement mediated binding of immune complexes to erythrocytes. They are sensitive, easy to perform and do not require expensive facilities. By measuring the interaction of complement with immune complexes, these methods may highlight aspects of the classical and the alternative pathway that are different from those detected using haemolysis as an endpoint.
KW - Alkaline Phosphatase
KW - Antigen-Antibody Complex
KW - Centrifugation
KW - Complement C2
KW - Complement System Proteins
KW - Dose-Response Relationship, Immunologic
KW - Humans
KW - Immune Complex Diseases
KW - Immunoenzyme Techniques
KW - Precipitin Tests
KW - Reference Values
KW - Reproducibility of Results
KW - Solubility
KW - Time Factors
KW - Alkaline Phosphatase
KW - Antigen-Antibody Complex
KW - Centrifugation
KW - Complement C2
KW - Complement System Proteins
KW - Dose-Response Relationship, Immunologic
KW - Humans
KW - Immune Complex Diseases
KW - Immunoenzyme Techniques
KW - Precipitin Tests
KW - Reference Values
KW - Reproducibility of Results
KW - Solubility
KW - Time Factors
U2 - 10.1016/S0022-1759(98)00199-9
DO - 10.1016/S0022-1759(98)00199-9
M3 - Article
C2 - 10037233
SN - 0022-1759
JO - Journal of Immunological Methods
JF - Journal of Immunological Methods
ER -